No evidence for increased skin cancer risk in psoriasis patients treated with broadband or narrowband UVB phototherapy: A first retrospective study

Acta Dermato-Venereologica

Volumn 84, Issue 5, 2004, Pages 370-374

  Weischer, Maren ^a   Blum, Andreas ^a   Eberhard, Frank ^a   Röcken, Martin ^a   Berneburg, Mark ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

Broadband UVB; Narrowband UVB; Phototherapy; Psoriasis; Retrospective study; Skin cancer risk; Ultraviolet light

Indexed keywords

ADULT; ARTICLE; CANCER CENTER; CANCER INCIDENCE; CANCER RISK; CONTROLLED STUDY; FEMALE; GERMANY; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOTOTHERAPY; PILOT STUDY; PRIORITY JOURNAL; PSORIASIS; PUVA; RADIATION DOSE; RETROSPECTIVE STUDY; SKIN CANCER; SKIN CARCINOGENESIS; STATISTICAL ANALYSIS; ULTRAVIOLET B RADIATION;

CARCINOMA IN SITU; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; PILOT PROJECTS; PSORIASIS; RETROSPECTIVE STUDIES; RISK; SKIN NEOPLASMS; ULTRAVIOLET THERAPY;

EID: 4744339221     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.1080/00015550410026948     Document Type: Article

References (39)

1. Berneburg M, Krutmann J. Photoimmunology, DNA repair and photocarcinogenesis. J Photochem Photobiol B 2000; 54: 87-93.
2. de Gruijl FR. Photocarcinogenesis: UVA vs. UVB radiation. Skin Pharmacol Appl Skin Physiol 2002; 15: 316-320.
3. Kripke ML. Antigenicity of murine skin tumors induced by ultraviolet light. J Natl Cancer Inst 1974; 53: 1333-1336.
4. Kripke ML. Immunology mechanisms in UV radiation carcinogenesis. Adv Cancer Res 1981; 34: 69-106.
5. Schwarz T. Effekte von ultravioletter Strahlung auf das Immunsystem. JDDG 2003; 2: 142-149.
6. Van Weelden H, De La Faille HB, Young E, Van der Leun JC. A new development in UVB phototherapy of psoriasis. Br J Dermatol 1988; 119: 11-19.
7. Grundmann-Kollmann M, Behrens S, Podda M, Peter RU, Kaufmann R, Kerscher M. Phototherapy for atopic eczema with narrowband UVB. J Am Acad Dermatol 1999; 40: 995-997.
8. Pascale VM, Diederen M, van Weelden Huib, Cornelus J, Sanders G, Toonstra J, et al. Narrowband UVB and psoralen-UVA in the treatment of early-stage mycosis fungoides: a retrospective study. J Am Acad Dermatol 2003; 48: 215-219.
9. Gathers RC, Scherschun L, Malick F, Fivenson DP, Lim HW. Narrowband UVB phototherapy for early-stage mycosis fungoides. J Am Acad Dermatol 2002; 47: 191-197.
10. Scherschun L, Kim JJ, Lim HW. Narrow-band ultraviolet B is a useful and well-tolerated treatment for vitiligo. J Am Acad Dermatol 2001; 44: 999-1003.
11. Studniberg HM, Weller P. PUVA, UVB, psoriasis, and nonmelanoma skin cancer. J Am Acad Dermatol 1993; 29: 1013-1022.
12. Paul CF, Ho VC, McGeown C, Christophers E, Schmidtmann B, Guillaume JC, et al. Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study. J Invest Dermatol 2003; 120: 211-216.
13. Stern RS, Laird N. The carcinogenic risk of treatments for severe psoriasis. Photochemotherapy follow-up study. Cancer 1994; 73: 2759-2764.
14. Stern RS, Nichols KT, Vakeva LH. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA follow-up study. N Engl J Med 1997; 336: 1041-1045.
15. Nijsten TE, Stern RS. The increased risk of skin cancer is persistent after discontinuation of psoralen + ultraviolet A: a cohort study. J Invest Dermatol 2003; 121: 252-258.
16. Ahrens C, Grewe M, Berneburg M, Grether-Beck S, Quiliet X, Mezzina M, et al. Photocarcinogenesis and inhibition of intercellular adhesion molecule1 expression in cells of DNA-repair-defective individuals. Proc Natl Acad Sci USA 1997; 94: 6837-6841.
17. Vink AA, Shreedhar V, Roza L, Krutmann J, Kripke ML. Cellular target of UVB-induced DNA damage resulting in local suppression of contact hypersensitivity. J Photochem Photobiol B 1998; 44: 107-111.
18. Yarosh D, Bucana C, Cox PA, Alas L, Kibitel J, Kripke M. Localization of liposomes containing a DNA repair enzyme in murine skin. J Invest Dermatol 1994; 103: 461-468.
19. Vink AA, Strickland FM, Bucana C, Cox PA, Roza L, Yarosh DB, et al. Localization of DNA damage and its role in altered antigen-presenting cell function in ultraviolet-irradiated mice. J Exp Med 1996; 183: 1491-1500.
20. El-Ghorr AA, Norval M. Biological effects of narrowband (311 nm TL01) UVB irradiation: a review. J Photochem Photobiol B 1997; 38: 99-106.
21. Wulf HC, Hansen AB, Bech-Thomsen N. Differences in narrowband ultraviolet-B and broadspectrum ultraviolet photocarcinogenesis in lightly pigmented hairless mice. Photoderm Photoimmunol Photomed 1994; 10: 192-197.
22. Young A. Carcinogenicity of UVB phototherapy asessed. Lancet 1995; 345: 1431-1432.
23. Flindt-Hansen H, McFadden N, Eeg-Larsen T, Thune P. Effect of a new narrowband UVB lamp on photocarcinogenesis in mice. Acta Derm Venereol 1991; 71: 245-248.
24. Morison WL, Baughman RD, Day RM, Forbes PD, Hoenigsmann H, Krueger GG, et al. Consensus workshop on the toxic effects of long-term PUVA therapy. Arch Dermatol 1998; 134: 595-598.
25. Fischer T. UV-light treatment of psoriasis. Acta Derm Venereol 1976; 56: 473-479.
26. Parrish JA, Jaenicke KF. Action spectrum for phototherapy of psoriasis. J Invest Dermatol 1981; 76: 359-362.
27. www.krebsinformation.de
28. Lewis FM, Shak M, Messenger AG, Thomas WEG. Metastatic squamous cell carcinoma in patients receiving PUVA. Lancet 1994; 344: 1157.
29. Gibbs NK, Honigsmann H, Young AR. PUVA treatment strategies and cancer risks. Lancet 1986; i: 150-151.
30. Young AR. Photocarcinogenicity of psoralens used in PUCA treatment: present status in mouse and man. J Photochem Photobiol 1990; 6: 237-247.
31. Stern RS, and members of the photochemotherapy follow-up study. Genital tumors among men with psoriasis exposed to psoralen and ultraviolet A radiation (PUVA) and ultraviolet B radiation. N Engl J Med 1990; 322: 1093-1097.
32. Lever LR, Farr PM. Skin cancers or premalignant lesions occur in half of high-dose PUVA-patients. Br J Dermatol 1994; 131: 215-219.
33. Lebwohl M. Should we switch from combination UVA/UVB phototherapy units to narrowband UVB? Photodermatol Photoimmunol Photomed 2002; 18: 44-46.
34. Pittelkow MR, Perry HO, Müller SA, Maughan WZ, O'Brien PC. Skin cancer in patients with psoriasis treated with coal tar. A 25-year follow-up study. Arch Dermatol 1981; 117: 465-468.
35. Gibbs NK, Norval M, Traynor NJ, Crosby JC, Lowe G, Johnson BE. Comparative potency of broadband and narrowband phototherapy sources to induce edema, sunburn cells and urocanic acid photoisomerization in hairless mouse skin. Photochem Photobiol 1993; 58: 643-647.
36. El-Ghorr AA, Norval M. Biological effects of narrowband (311 nm TL01) UVB irradiation: a review. Photochem Photobiol 1997; 38: 99-106.
37. Degitz K, Messer G, Röcken M. Schmalspektrum-UVB 311nm versus Breitspektrum-UVB. Hautarzt 1998; 49: 795-806.
38. Walter IB, Burack LH, Coven TR, Gilleaudeau P, Krueger JG. Suberythemogenic narrow-band UVB is markedly more effective than conventional UVB in treatment of psoriasis vulgaris. J Am Acad Dermatol 1999; 40: 893-900.
39. Coven TR, Burack LH, Gilleaudeau R, Keogh M, Ozawa M, Krueger JG. Narrowband UV-B produces superior clinical and histopathological resolution of moderate-to-severe psoriasis in patients compared with broadband UV-B. Arch Dermatol 1997; 133: 1514-1522.